Broadcom stock is up nearly 300% over the last three years, and Taiwan Semiconductor has gained 370%. Broadcom designs custom AI accelerators and networking chips, while TSMC manufactures advanced chips for companies including Nvidia, AMD, Apple and Broadcom. The author says he would choose TSMC over the next five years because it benefits from demand across a broader group of chip designers, whereas Broadcom's success depends partly on winning custom chip designs from major customers. The article also notes TSMC's risks, including heavy capital spending and higher costs for its Arizona facilities.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Keywords
TSMCBroadcomsemiconductorsartificial intelligence
Open a keyword to see other news on the same topic.
Related news
- 2 Millionaire-Maker Custom Silicon Stocks Powering the AI Infrastructure Supercycle
The article profiles Broadcom and Taiwan Semiconductor Manufacturing (TSMC) as leading custom-silicon players. Broadcom, which partners with Alphabet on TPUs and counts Meta, OpenAI, and Anthropic among its ASIC customers, reported third-quarter AI semiconductor revenue up 221% to $16.7 billion and net income up roughly 216% to $13.1 billion. It expects fourth-quarter AI revenue to rise 236% to $21.7 billion, and the stock trades at about 28 times expected earnings this year. TSMC manufactures chips designed by its customers and, according to many estimates, controls over 90% of the high-end AI chip market. Its stock has delivered a total return of roughly 4,720% over 15 years. The author notes that both stocks' valuations have been volatile amid AI bubble concerns, while their market positions remain strong.
- $3,000 Split Across Nvidia, Broadcom, and TSMC Could Be Worth This Much by 2030
The author suggests that a $3,000 stake split among five shares of Nvidia, three of Broadcom, and two of Taiwan Semiconductor could grow to over $9,000 by the end of 2030, if AI infrastructure spending keeps expanding. For Nvidia, analysts expect fiscal 2031 revenue near $1.2 trillion, while the author's own estimate is over $1.9 trillion, which at a 20 forward P/E implies about $830 per share. Broadcom's custom AI chip business is projected to double twice to $230 billion, and with EPS of $52.15 at a 20 forward P/E, the stock could trade near $1,043. TSMC, the world's largest foundry, is assumed to reach adjusted EPS of about $48.35 in 2031, implying roughly $967 per share. The main risk noted is an AI slowdown.
- Broadcom’s Supply Bottlenecks – Not Demand – Continue to Offer Investors a Discount I Keep Buying
The author says they increased their Broadcom (AVGO) position and plans to add more after the next earnings report, citing a stock close of $326.08 on October 30, down 12.74% over the past year even as quarterly revenue rose 85.5%. CEO Hock Tan said customer demand for custom AI chips exceeds an outlook of about $115 billion for fiscal 2027, and that the company will work to improve supply constraints. AI semiconductor revenue reached $16.70 billion in the third quarter, up 221%, while free cash flow was $13.665 billion and the $0.65 quarterly dividend yields about 0.8%. The author names customer concentration as the main risk, since Broadcom works closely with six XPU customers and expects Anthropic to become the largest in 2027. The author prefers Broadcom over NVIDIA (dividend yield about 0.13%) and AMD (129 times trailing earnings, no dividend).
- Broadcom Sinks 5.5% as Its $43 Billion Anthropic Backstop Meets an Intel-Led Chip Rout
Broadcom has committed to cover residual-value shortfalls on AI racks leased to Anthropic, with a maximum potential liability of about $43 billion on top of an earlier $29 billion backstop. The stock fell 5.5% to $326 in a chip sell-off that followed Intel's weak PC outlook. AI semiconductor revenue rose 221% to $16.7 billion last quarter, and management targets $115 billion of AI revenue for fiscal 2027. The article sees strong demand but argues that the combined roughly $72 billion exposure and reliance on a few customers warrant a deeper discount until those customers prove their revenue. The Street's $529 average price target implies 62% upside, and the December 10 report is the next checkpoint.
- Broadcom Stock Outlook Hinges On AI Chip Growth And Anthropic Partnership
Broadcom reported sharp growth in AI semiconductor revenue and expanded custom accelerator work with Anthropic and Meta, while its TrueSource Spring Enterprise release shipped 89 security fixes. The article says the outlook hinges on AI chip growth offsetting margin pressure, with Q4 2026 gross margin guided to 73% from 77.1% in Q2 2026 and about US$29b of potential exposure from AI XPV residual value guarantees. Analyst models assume revenue growth of about 52.7% a year and earnings rising from US$38.3b today to a consensus US$155.8b by 2029, implying a P/E of 23.0x versus 44.3x now. The consensus price target of US$531.85 sits above the current US$355.10 share price, though individual targets range from US$215.88 to US$715.00.
- History Says Now Is the Perfect Time to Buy Broadcom Stock
Broadcom shares have fallen about 30% from their all-time high set in early June and are roughly flat year to date. The author argues that more companies are choosing Broadcom's custom AI chips over general-purpose GPUs, which could drive strong growth. Management expects AI semiconductor revenue of $115 billion in 2027 and $230 billion in 2028, versus over $16 billion in the latest quarter, and says its supply chain is secured for this expansion. The stock trades at 28 times this year's earnings estimates and 17 times next year's, which the author says means little of the expected growth is priced in. The author expects the stock could double or triple over the next few years if current plans hold.
Related markets
Latest news
- AMD stock jumps 7% on earnings as data center revenue nearly doubles
AMD reported third-quarter revenue up 45% to $13.38 billion, beating the $13.09 billion LSEG consensus, while adjusted EPS came in at $2.09 versus $1.95 expected. Data center sales nearly doubled and now account for 64% of total revenue, up from 47% a year earlier, driven by demand for server CPUs that power agentic AI apps. The stock rose 7% in extended trading after recent losses. Its PC and gaming segment fell 8% to $3.7 billion, with gaming revenue down 40%. For the fourth quarter, AMD expects about $17 billion in revenue, above the $16.2 billion analyst average.
- CrowdStrike Launches AI Agent 'Kill Switch,' Plans to Acquire Fiddler AI
CrowdStrike launched an AI Kill Switch that lets administrators block unauthorized AI agents through a gateway, with direct endpoint termination planned later. The company also agreed to acquire Fiddler AI, reportedly valued at roughly $400 million, to monitor agent behavior and explain automated decisions. The tools aim to give enterprises more control over AI agents that can access corporate systems and act without constant human supervision. The Fiddler deal is expected to close in the fourth quarter of fiscal 2027, which ends January 31, 2027, and will be paid mainly in cash.
- How major US stock indexes fared Tuesday 11/3/2026
The S&P 500 rose 0.4% to 7,568.92 even though most of its stocks fell, while the Dow Jones Industrial Average lost 0.4% to 51,786.72 and the Nasdaq composite gained 0.8% to 25,372.01. Apple shares sank after the company warned it may earn less profit from each $1 of revenue as memory chip costs rise. Nvidia and other AI-related stocks rebounded after weeks of sharp swings, offsetting that drag. Oil prices fell. Year to date, the S&P 500 is up 10.6%, the Nasdaq up 9.2% and the Dow up 7.7%.
- Super Micro’s stock pops as earnings show booming demand for AI servers
CFO Mark Long told MarketWatch that Super Micro is building a “high-quality customer base” that is fueling revenue growth. The comments come as the company’s stock rose following its earnings report.
- Moderna's Cancer Vaccine Is Incredibly Promising, but This Could Be a Major Obstacle to Its Success
Moderna (MRNA) shares have risen more than 600% so far this year and over 800% in the past 12 months, on hopes for intismeran, a personalized cancer vaccine developed with Merck. In trials, the vaccine combined with Merck's Keytruda cut the risk of death and melanoma recurrence by 42% compared with Keytruda alone. Its custom manufacturing process can span six weeks, which may keep costs high and limit economies of scale. One analyst projects peak annual sales above $5 billion for melanoma alone. Citing a valuation of around $90 billion, the author says too much future growth is already priced in and places the stock on a watch list.
- Super Micro Computer (SMCI) Stock Dropped, So What Is Driving Attention Now?
Super Micro Computer (SMCI) shares have fallen sharply, down 30.3% over one month and 7.6% in the latest session, after the company added the NVIDIA Vera CPU rack to its Data Center Building Block Solutions portfolio. The article says investors are reassessing AI-related risks and margin expectations. An analysis by RogueEP puts fair value at $55.85 per share versus a last close of $30.44, and rates the stock positively. Its model uses an 11.4% WACC and assumes AI capex could fall 48% from peak to trough, with a reference price of $38.09. The article also flags risks that AI capex could slow faster than expected or that thin margins could compress further.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.